"bms" の関連情報検索結果
Harbour BioMed inks license deal with BMS - The Pharma Letter

Harbour BioMed inks license deal with BMS The Pharma Letter
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B Fierce Biotech
Champions in Care - Bristol Myers Squibb

Champions in Care Bristol Myers Squibb
Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myer...

Harbour Biomed closes busy year with $1B+ BMS deal - BioWorld MedTech

Harbour Biomed closes busy year with $1B+ BMS deal BioWorld MedTech
Harbour BioMed and BMS sign multi-specific antibody collab - Pharmaceutical Technology

Harbour BioMed and BMS sign multi-specific antibody collab Pharmaceutical Technology
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour BioSpace
BMS Jumps Aboard Harbour’s R&D Ship - Citeline News & Insights

BMS Jumps Aboard Harbour’s R&D Ship Citeline News & Insights
BMS strikes $1.1B multispecific antibody pact with Harbour - FirstWord Pharma

BMS strikes $1.1B multispecific antibody pact with Harbour FirstWord Pharma
Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies - Contract Pharma

Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies Contract Pharma
The evolution of wireless BMS in EVs and high-voltage systems - EVreporter •

The evolution of wireless BMS in EVs and high-voltage systems EVreporter •
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology - TipRanks

Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology TipRanks
BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC - Clinical Trials Arena

BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC Clinical Trials Arena
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis Fierce Pharma
BMS tickets on sale at Food City locations - Kingsport Times News

BMS tickets on sale at Food City locations Kingsport Times News
BMS sets India entry via Berns Brett partnership - Insurance Business

BMS sets India entry via Berns Brett partnership Insurance Business
Building a healthier future together: Strengthening cancer care across Africa through partnership...

Building a healthier future together: Strengthening cancer care across Africa through partnership Bristol Myers Squibb
Backed by J&J and BMS, Link Cell debuts with logic-gated CAR-T playbook - FirstWord Pharma

Backed by J&J and BMS, Link Cell debuts with logic-gated CAR-T playbook FirstWord Pharma
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study BioSpace
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) Bristol Myers Squibb
CAR T cell therapy patient resources - Bristol Myers Squibb

CAR T cell therapy patient resources Bristol Myers Squibb
Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 20...

Global Inclusion - Bristol Myers Squibb

Global Inclusion Bristol Myers Squibb
Become a business supplier - Bristol Myers Squibb

Become a business supplier Bristol Myers Squibb
Global Patient Week - Bristol Myers Squibb

Global Patient Week Bristol Myers Squibb
Independent research - Bristol Myers Squibb

Independent research Bristol Myers Squibb
About us - Bristol Myers Squibb

About us Bristol Myers Squibb
Business development leadership team - Bristol Myers Squibb

Business development leadership team Bristol Myers Squibb
Why Bristol-Myers Squibb (BMY) Stock Is Up Today - Yahoo Finance

Why Bristol-Myers Squibb (BMY) Stock Is Up Today Yahoo Finance
Merck, Bristol Myers Squibb plan NJ layoffs (updated) - NJBIZ

BMS strengthens MENA and India presence with DIFC launch and new partnership - Intelligent Insurer

BMS strengthens MENA and India presence with DIFC launch and new partnership Intelligent Insurer
Bristol Myers Squibb donates $32K to fund lab equipment for charter school - ROI-NJ

Bristol Myers Squibb donates $32K to fund lab equipment for charter school ROI-NJ
Chris Shibutani, MD - Bristol Myers Squibb

Chris Shibutani, MD Bristol Myers Squibb
Our technologies - Bristol Myers Squibb

Our technologies Bristol Myers Squibb
Transparency & reporting - Bristol Myers Squibb

Transparency & reporting Bristol Myers Squibb
APMT, BMS sign Apapa lease through 2031 - Port Technology

APMT, BMS sign Apapa lease through 2031 Port Technology
By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway - Speedway Digest

By the Numbers: Food City Speedway in Lights at Bristol Motor Speedway Speedway Digest
Our research in neuroscience - Bristol Myers Squibb

Our research in neuroscience Bristol Myers Squibb
Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program Bristol Myers Squibb
BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” - Clinical Trials Arena

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” Clinical Trials Arena
BMS Group expands in India with Berns Brett partnership - theinsurer.com

BMS Group expands in India with Berns Brett partnership theinsurer.com
The Bristol Myers Squibb Foundation - Bristol Myers Squibb

The Bristol Myers Squibb Foundation Bristol Myers Squibb
BMS Group Announces Further Expansion - - Insurance Edge

BMS Group Announces Further Expansion - Insurance Edge
Driving patient-centric care through global patient outreach - Bristol Myers Squibb

Driving patient-centric care through global patient outreach Bristol Myers Squibb
Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies - ge...

Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies geneonline.com
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...

Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules - Reuters

Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules Reuters
Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing Fierce Pharma
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...

Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it? Bristol Myers Squibb
Areas of interest - Bristol Myers Squibb

Areas of interest Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb

RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs Bristol Myers Squibb
Privacy notice center - Bristol Myers Squibb

Privacy notice center Bristol Myers Squibb
Bristol Myers Squibb, Accenture launch AI-powered content hub ‘Mosaic’ in Mumbai - ETPharma.com

Bristol Myers Squibb, Accenture launch AI-powered content hub ‘Mosaic’ in Mumbai ETPharma.com
People and business resource groups - Bristol Myers Squibb

People and business resource groups Bristol Myers Squibb
BMS launches in the DIFC as regional expansion continues - Global Reinsurance

BMS launches in the DIFC as regional expansion continues Global Reinsurance
BMS Group Forms Partnership With Berns Brett India - - Insurance Edge

BMS Group Forms Partnership With Berns Brett India - Insurance Edge
Cambridge biotech receives $255M in sale of spinout to BMS - The Business Journals

Cambridge biotech receives $255M in sale of spinout to BMS The Business Journals
Why RV Energy Storage Lithium Batteries Cut Out After Bumps? BMS - openPR.com

Why RV Energy Storage Lithium Batteries Cut Out After Bumps? BMS openPR.com
FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease - NeurologyLive

FDA Fast Tracks Anti-MTBR-Tau-Targeting Antibody BMS-986446 for Alzheimer Disease NeurologyLive
Clinical trials & studies - Bristol Myers Squibb

Clinical trials & studies Bristol Myers Squibb
From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer - Bristol Myers Squibb

From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer Bristol Myers Squibb
Accenture helps Bristol Myers Squibb to launch AI-based medical content hub Mosaic - Times of India

Accenture helps Bristol Myers Squibb to launch AI-based medical content hub Mosaic Times of India
Psoriasis around the world - Bristol Myers Squibb

Psoriasis around the world Bristol Myers Squibb
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace
Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent ...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future Fierce Biotech
BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes Fierce Biotech
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia Fierce Biotech
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...

300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C Bristol Myers Squibb
Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma

Merck & Co., BMS to lay off over 300 staffers in New Jersey FirstWord Pharma
Our science - Bristol Myers Squibb

Our science Bristol Myers Squibb
Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration Bristol Myers Squibb
FDA Action Alert: BMS, GSK, Amgen and More - BioSpace

Honoring oncologists through the Time Back campaign - Bristol Myers Squibb

Honoring oncologists through the Time Back campaign Bristol Myers Squibb
Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva

Worldwide locations - Bristol Myers Squibb

Worldwide locations Bristol Myers Squibb
Internship insights: ‘Show initiative and lean into areas that spark interest’ - Silicon Republic

Internship insights: ‘Show initiative and lean into areas that spark interest’ Silicon Republic
Pre-approval access to investigational medicines - Bristol Myers Squibb

Pre-approval access to investigational medicines Bristol Myers Squibb
A global journey through BMS’ R&D hubs - Bristol Myers Squibb

A global journey through BMS’ R&D hubs Bristol Myers Squibb
BMS Strengthens Global Leadership with Cutting-Edge Roll Forming Machinery Solutions - FinancialC...

BMS Strengthens Global Leadership with Cutting-Edge Roll Forming Machinery Solutions FinancialContent
Our impact - Bristol Myers Squibb

Our impact Bristol Myers Squibb
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative ...

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection Bristol Myers Squibb
BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology

BMS expands CAR-T portfolio with $1.5bn Orbital buyout Pharmaceutical Technology
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line BioSpace
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma

BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial Fierce Biotech
Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Ca...

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise - Yahoo Finance

BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise Yahoo Finance
I-See-BMs: Chinese Nuclear Policy Under Xi Jinping - Foreign Policy Research Institute

I-See-BMs: Chinese Nuclear Policy Under Xi Jinping Foreign Policy Research Institute
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...

BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future Fierce Pharma
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC BioSpace
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb

Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
"Too many patients in rural America face barriers to cardiovascular care — barriers that - Bristo...

"Too many patients in rural America face barriers to cardiovascular care — barriers that Bristol Myers Squibb
Looking to the Future of Cell Therapy - Bristol Myers Squibb

Looking to the Future of Cell Therapy Bristol Myers Squibb
2025 Annual Meeting of Shareholders - Bristol Myers Squibb

2025 Annual Meeting of Shareholders Bristol Myers Squibb
Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya

Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS Kaseya
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma

BMS, Pfizer launch direct-to-consumer push for Eliquis in the US FirstWord Pharma
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech